Prostatitis/chronic pelvic pain syndrome

Annual Review of Medicine

Volumn 57, Issue , 2006, Pages 195-206

  Habermacher, Geoffrey M ^a   Chason, Judd T ^a   Schaeffer, Anthony J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Infection; Inflammation; Prostate

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BETA LACTAM ANTIBIOTIC; CERNITIN; CIPROFLOXACIN; COTRIMOXAZOLE; FINASTERIDE; INFUSION FLUID; PENTOSAN POLYSULFATE; QUERCETIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAMSULOSIN; TERAZOSIN;

ACUTE DISEASE; ALGORITHM; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; CHRONIC DISEASE; CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; EJACULATION DISORDER; FEEDBACK SYSTEM; HEALTH CARE ORGANIZATION; HUMAN; HYPERTHERMIC THERAPY; NONHUMAN; PAIN; PATHOGENESIS; PELVIC FLOOR MUSCLE TRAINING; PELVIS PAIN SYNDROME; PHYTOTHERAPY; PRIORITY JOURNAL; PROSTATITIS; REVIEW; SYMPTOMATOLOGY; TREATMENT RESPONSE; URINARY TRACT DISEASE; URINARY TRACT INFECTION;

HUMANS; MALE; PELVIC PAIN; PROSTATITIS; SYNDROME;

EID: 32944470216     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.57.011205.135654     Document Type: Review

References (51)

1. Krieger JN, Ross SO, Riley DE. 2002. Chronic prostatitis: epidemiology and role of infection. Urology 60:8-13
2. Roberts RO, Lieber MM, Rhodes T, et al. 1998. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of urinary symptoms and health status among men. Urology 51:578-84
3. Mehik A, Hellstrom P, Lukkarinen O, et al. 2000. Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study. Br. J. Urol. Int. 86:443-48
4. McNaughton-Collins M, Stafford RS, O'Leary MP, et al. 1998. How common is prostatitis? A national survey of physician visits. J. Urol. 159:1224-28
5. Drach GW, Fair WR, Meares EM, et al. 1978. Classification of benign disease associated with prostatic pain: prostatitis or prostatodynia? J. Urol. 120:266
6. Meares EM, Stamey TA. 1968. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest. Urol. 5:492-518
7. Krieger JN, Nyberg L, Nickel JC. 1999. NIH consensus definition and classification of prostatitis. JAMA 282:236-37
8. Litwin MS, McNaughton-Collins MM, Fowler FJ Jr., et al. 1999. The National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI): development and validation of a new outcome measure. J. Urol. 162:369-75
9. Alexander RB, Propert KJ, Schaeffer AJ, et al. 2004. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome. Ann. Intern. Med. 141:581-89
10. Nickel JC, Downey J, Clark J, et al. 2003. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 62:614-17
11. Meares EM Jr. 1987. Acute and chronic prostatitis: diagnosis and treatment. Infect. Dis. Clin. North Am. 1:855-73
12. Domingue GJ Sr., Hellstrom WJ. 1998. Prostatitis. Clin. Microbiol. Rev. 11(4):604-13
13. Terai A, Ishitoya S, Mitsumori K, et al. 2000. Molecular epidemiological evidence for ascending urethral infection in acute bacterial prostatitis. J. Urol. 164:1945-47
14. Fowler JE Jr. 2002. Antimicrobial therapy for bacterial and nonbacterial prostatitis. Urology 60:24-26
15. Leport C, Rousseau F, Perronne C, et al. 1989. Bacterial prostatitis in patients infected with the human immunodeficiency virus. J. Urol. 141:334-36
16. Schaeffer AJ. 2002. Infections of the urinary tract. In Campbell's Urology, ed. PC Walsh, pp. 516-92. Philadelphia: Saunders
17. Okada K, Kojima M, Naya Y, et al. 2000. Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer. Urology 55(6):892-98
18. Schaeffer AJ, Wendel EF, Dunn JK, et al. 1981. Prevalence and significance of prostatic inflammation. J. Urol. 125:215-19
19. Weidner W, Schiefer HG, Krauss H, et al. 1991. Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Infection 19:5119-25
20. Wright ET, Chmiel JS, Grayhack JT, et al. 1994. Prostatic fluid inflammation in prostatitis. J. Urol. 152:1-3
21. Weidner W, Ludwig M. 1994. Diagnostic management of chronic prostatitis. In Prostatitis: Etiopathology, Diagnosis, and Therapy, ed. W Weidner, PO Madsen, HG Schiefer, pp. 58-74. Berlin: Springer
22. Schaeffer AJ, Darras FS. 1990. The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim- sulfamethoxazole and/or carbenicillin. J. Urol. 144:690-93
23. Weidner W, Schiefer HG, Brahler E. 1991. Refractory chronic bacterial prostatitis: a reevaluation of ciprofloxacin treatment after median follow-up of 30 months. J. Urol. 146:350-52
24. Schaeffer AJ. 1990. Diagnosis and treatment of prostatic infections. Urology 36:13-17
25. Doble A. 1994. Chronic prostatitis. Br. J. Urol. 74:537-41.
26. Yamamoto M, Hibi H, Satoshi K, et al. 1996. Chronic bacterial prostatitis treated with intraprostatic injection of antibiotics. Scand. J. Urol. Nephrol. 30:199-202
27. Meares EM Jr. 1980. Prostatitis syndromes: new perspectives about old woes. J. Urol. 123:141-47
28. Hua VN, Schaeffer AJ. 2004. Acute and chronic prostatitis. Med. Clin. North Am. 88:483-94
29. Fowler JE. 2002. Antimicrobial therapy for bacterial and nonbacterial prostatitis. Urology 60:24-26
30. Krieger JN, Egan KJ, Ross SO, et al. 1996. Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis." Urology 48:715-22
31. Krieger JN, Jacobs RR, Ross SO. 2000. Does the chronic prostatitis/pelvic pain syndrome differ from nonbacterial prostatitis and prostatodynia? J. Urol. 164:1554-58
32. Schaeffer AJ, Datta NS, Fowler JE Jr., et al. 2002. Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Urology 60(6 Suppl.):1-4.
33. Schaeffer AJ, Landis JR, Knauss JS, et al. 2002. Demographic and clinical characteristics of men with chronic prostatitis: the NIH Chronic Prostatitis Cohort (CPC) Study. J. Urol. 168:593-98
34. Pontari MA, Ruggieri MR. 2004. Mechanisms in prostatitis/chronic pelvic pain syndrome. J. Urol. 172(3):839-45
35. Simmons PD, Thin RN. 1985. Minocycline in chronic abacterial prostatitis: a double-blind prospective trial. Br. J. Urol. 57:43-45
36. Nickel JC. 2004. The three As of chronic prostatitis therapy: antibiotics, α-blockers, and anti-inflammatories. What is the evidence? Br. J. Urol. Int. 94:1230-33
37. Datta NS. 2002. Role of α-blockers in the treatment of chronic prostatitis. Urology 60:27-28
38. Cheah PY, Liong ML, Yuen KH, et al. 2003. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo-controlled trial. J. Urol. 169:592-96
39. Nickel JC, Narayan P, McKay J, et al. 2004. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double-blind trial. J. Urol. 171:1594-97
40. Nickel JC, Pontari M, Moon T, et al. 2003. A randomized, placebo-controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J. Urol. 169:1401-5
41. Shoskes DA, Zeitlin SI, Shahed A, et al. 1999. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-control trial. Urology 54:960-453
42. Nickel JC, Forrest J, Tomera KM, et al. 2005. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multi-center randomized, placebo controlled study. J. Urol. 173(4):1252-55
43. Nadler RB. 2002. Bladder training biofeedback and pelvic floor myalgia. Urology 60:42-44
44. Clemens JQ, Nadler RB, Schaeffer AJ, et al. 2000. Biofeedback, pelvic floor reeducation, and bladder training for male chronic pelvic pain syndrome. Urology 56:951-55
45. Nickel JC, Siemens DR, Johnston B. 1998. Transurethral radiofrequency hot balloon thermal therapy in chronic nonbacterial prostatitis. Tech. Urol. 4(3):128-30
46. Deleted in proof
47. Potts JM. 2000. Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen. J. Urol. 164:214-18
48. Carver BS, Bozeman CB, Williams BJ, et al. 2003. The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen. J. Urol. 169:589-91
49. Nadler RB, Koch AE, Calhoun EA, et al. 2000. IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J. Urol. 164:214-18
50. Hochreiter WW, Nadler RB, Koch AE, et al. 2000. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology 56:1025-29
51. Bennett RM. 2002. The rational management of fibromyalgia patients. Rheum. Dis. Clin. North Am. 28(2):181-99